NCT04305535 - Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

June 30, 2021

Conditions

Crohn DiseaseAbsorption; Disorder, ProteinAbsorption; DisorderAbsorption; Disorder, FatAbsorption; Disorder, CarbohydrateMalnutrition

Interventions

DIETARY_SUPPLEMENT

Peptidic+Probiotic

"Oligomeric oral nutritional supplement (Bi1 peptidic) and a mix of probiotics~* Bifidobacterium animalis subsp. lactis BPL1,~* Lactobacillus rhamnosus BPL15,~* Lactobacillus rhamnosus CNCM i-4036~* Bifidobacterium longum ES1"

DIETARY_SUPPLEMENT

Peptidic+Placebo

Oligomeric oral nutritional supplement (Bi1 peptidic) and a placebo

DIETARY_SUPPLEMENT

Polymeric+Placebo

Polymeric oral nutritional supplement and a placebo

Trial Locations (1)

28040

RECRUITING

Miguel Aganzo Yeves, Madrid